Wockhardt

Last updated

Wockhardt Ltd.
Company type Public
NSE:  WOCKPHARMA
BSE:  532300
Industry Pharmaceuticals
Health care
Founded1960s
Founder Habil Khorakiwala
HeadquartersWockhardt Towers, Bandra Kurla Complex, Mumbai, Maharashtra, India
Area served
Worldwide
Key people
Habil Khorakiwala (Chairman)
Murtaza Khorakiwala (Managing director)
Huzaifa Khorakiwala (Executive Director)
Products Formulations
Biopharmaceuticals
Vaccines
RevenueDecrease2.svg₹2,693 crore (US$310 million) (FY23) [1]
Increase Negative.svg₹−621 crore (US$−72 million) (FY23) [1]
Number of employees
3,000 (2023)
Subsidiaries Morton Grove Pharma [2]
Website www.wockhardt.com
Footnotes /references
[3]

Wockhardt is an Indian pharmaceutical and biotechnology company headquartered in Mumbai, India. It produces formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients (APIs). [4] The company has manufacturing plants in India, UK, Ireland, France and US, and subsidiaries in US, UK, Ireland and France. [5] [6]

Contents

History

Wockhardt was founded by Dr. Habil Khorakiwala in the 1960s. [7] His father Fakhruddin T. Khorakiwala had acquired Worli Chemical Works [8] in 1959. This was incorporated as Wockhardt Pvt. Ltd., in 1973. [5] Wockhardt Ltd. was incorporated on 8 July 1999. [9] In the 1990s, Wockhardt gained market share with its painkiller Proxyvon (opioid tramadol + paracetamol) and blood pressure drugs (lisinopril, etc.). In 1995, it expanded into biotechnology, and subsequently started producing intravenous fluids. [10] In 1999, Dr. Reddy's joined the Indian Pharmaceutical Alliance as a founding member in an effort to promote the development of generic drugs in India. [11] [12]

Wockhardt is the first company outside the US and Europe to manufacture recombinant human insulin. [13]

In 2011, Wockhardt sold its nutrition business to Danone for $356 million. [14]

During the COVID-19 pandemic, Wockhardt signed a contract with the Government of the United Kingdom to fill-finish the Oxford–AstraZeneca COVID-19 vaccine at the company's facility in Wrexham, Wales. The contract was extended until August 2022. [15] [16]

In August 2021, Wockhardt announced that it signed an agreement with Dubai-based Enso Healthcare and Russian firm Human Vaccine LLC to contract manufacture the Sputnik V and Sputnik Light vaccines in India. [17]

Mergers and acquisitions

Wockhardt's acquisitions include Wallis Laboratory, UK (1998); Merind, India (1998); CP Pharmaceuticals, UK (2003); Espharma GmbH, Germany (2004); Dumex, India (2006); Pinewood Laboratory Ireland (2006); Morton Grove Pharmaceuticals, US (2007); [18] and Negma, France (2007). [5] Wockhardt's debt following the acquisitions was close to Rs 38 billion, and Habil Khorakiwala quit as managing director. [19]

The board of directors, on 31 March 2009 approved the appointments of Habil Khorakiwala's sons Murtaza Khorakiwala and Huzaifa Khorakiwala as managing director and executive director respectively. [20]

Philanthropy and education

Wockhardt Global School in Aurangabad WOCKHARDT 5.jpg
Wockhardt Global School in Aurangabad

Wockhardt is known for producing cough syrup with the sedative promethazine and the opiate codeine, used in the recreational street drug lean, which is sometimes referred to as "Wock", short for Wockhardt. [21]

Good Manufacturing Practice violations

Wockhardt received a FDA warning letter 25 November 2013 identifying significant violations of current good manufacturing practice for finished pharmaceuticals at the Chikalthana and Waluj facilities. [22]

A warning letter sent 18 July 2013 referring to an 18 March inspection of the Waluj facility, Aurangabad cited repeatedly delayed, denied or limited an FDA inspection. Citations included destruction of raw analytical data, destruction of analytical samples, lying by both the production head and vice-president of Manufacturing to the FDA Inspector.

Specific GMP violations dein Vater included failure to prepare batch production records for drug products, attempts to hide manufacturing for the USA market from inspection, use of 'trial' analyses and 'official' analyses to attempt to hide failing or out of specification results, inability to demonstrate integrity of computer records, no audit system for computer records, faked training records for critical GMP activities, and inadequate washing and toilet facilities. [23]

See also

Related Research Articles

<span class="mw-page-title-main">Food and Drug Administration</span> United States federal agency

The United States Food and Drug Administration is a federal agency of the Department of Health and Human Services. The FDA is responsible for protecting and promoting public health through the control and supervision of food safety, tobacco products, caffeine products, dietary supplements, prescription and over-the-counter pharmaceutical drugs (medications), vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices (ERED), cosmetics, animal foods & feed and veterinary products.

Ranbaxy Laboratories Limited was an Indian multinational pharmaceutical company that was incorporated in India in 1961 and remained an entity until 2014. The company went public in 1973. Ownership of Ranbaxy changed twice over the course of its history.

<span class="mw-page-title-main">Good manufacturing practice</span> Manufacturing quality standards

Current good manufacturing practices (cGMP) are those conforming to the guidelines recommended by relevant agencies. Those agencies control the authorization and licensing of the manufacture and sale of food and beverages, cosmetics, pharmaceutical products, dietary supplements, and medical devices. These guidelines provide minimum requirements that a manufacturer must meet to assure that their products are consistently high in quality, from batch to batch, for their intended use.

<span class="mw-page-title-main">Dr. Reddy's Laboratories</span> Indian multinational pharmaceutical company

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology.

<span class="mw-page-title-main">Biocon</span> Indian multinational biopharmaceutical company

Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, India. It was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.

The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. It is also the largest vaccine supplier in the world by volume, accounting for more than 60% of all vaccines manufactured in the world. Indian pharmaceutical products are exported to various regulated markets including the US, UK, European Union and Canada.

<span class="mw-page-title-main">Hetero Drugs</span> An Indian pharmaceutical company

Hetero Drugs is an Indian pharmaceutical company and the world's largest producer of anti-retroviral drugs. Hetero's business includes APIs, generics, biosimilars, custom pharmaceutical services, and branded generics.

<span class="mw-page-title-main">Zydus Lifesciences</span> Indian multinational pharmaceutical company

Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an Indian multinational pharmaceutical company headquartered in Ahmedabad, which is primarily engaged in the manufacturing of generic drugs. The company ranked 100th in the Fortune India 500 list in 2020.

<span class="mw-page-title-main">McGuff Companies</span> American health care company

The McGuff Companies consist of three entities: a wholesale distributor of medical supplies, a pharmaceutical manufacturing facility which produces sterile injectables for national and international distribution, and a 503B outsourcing facility. The McGuff Companies have been featured in the International Journal of Pharmaceutical Compounding (IJPC).

<span class="mw-page-title-main">Ipca Laboratories</span> Indian multinational pharmaceutical company

Ipca Laboratories Limited is an Indian multinational pharmaceutical company based in Mumbai. It produces theobromine, acetylthiophene, and p-bromotoluene as active pharmaceutical ingredients (APIs). Ipca sells these APIs and their intermediates globally. It produces more than 150 formulations that include oral liquids, tablets, dry powders, and capsules.

Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals.

<span class="mw-page-title-main">Intas Pharmaceuticals</span> Indian multinational pharmaceutical company

Intas Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Ahmedabad. It is a producer of generic therapeutic drugs and engaged in contract clinical research and manufacturing. It has 22 manufacturing plants, 17 in India and the rest in Greece, United Kingdom and Mexico. In the financial year 2019, 69% of the company's revenue came from international markets while 31% came from India. Its market presence is in more than 100+ countries.

Pharmaceutical fraud is when pharmaceutical companies engage in illegal, fraudulent activities to the detriment of patients and/or insurers. Examples include counterfeit drugs that do not contain the active ingredient, false claims in packaging and marketing, suppression of negative information regarding the efficacy or safety of the drug, and violating pricing regulations.

<span class="mw-page-title-main">Enso Group</span> Diversified multinational conglomerate

Enso Group is a multinational diversified conglomerate. The group was founded in 2005 by Chairman Vinay Maloo. It was started with a cluster of oil and gas exploration and production companies in Jordan, Nigeria, Georgia, Australia and India. The group has consultancy arms in the UK and Singapore with operational offices globally. Most of the group companies are privately held. Vaibhav Maloo holds the position of managing director of the group. Enso Oils & Lubricants is the Indian partner for Gazprom Neft engine oils. Enso Global Trading is a trading house based out of Dubai.

<span class="mw-page-title-main">Wockhardt Hospitals</span> Indian hospital chain

Wockhardt Hospitals Ltd is an Indian for-profit private hospital network headquartered in Mumbai. The chain of hospitals is owned by the promoters of Wockhardt, a multinational pharmaceutical company. It has six hospitals across four western Indian cities–Mumbai, Nagpur, Nashik and Rajkot.

<span class="mw-page-title-main">Cadila Pharmaceuticals</span> Indian pharmaceutical company

Cadila Pharmaceuticals is an Indian multinational pharmaceutical company based in Ahmedabad. The company's operations focus on manufacturing products ranging from active pharmaceutical intermediates, finished formulations, food supplements, biotechnology products and pharmaceutical machinery.

Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020.

<span class="mw-page-title-main">Covaxin</span> Vaccine against COVID-19

Covaxin is a whole inactivated virus-based COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research - National Institute of Virology.

Habil Khorakiwala is the founder and Chairman of Indian multinational pharmaceutical and biotechnology company Wockhardt. He founded Wockhardt in 1967, which since then has grown into one of the top Indian makers of generic drugs, formulations, biopharmaceuticals, nutrition products, vaccines, active pharmaceutical ingredients (APIs) and a chain of advanced Super Speciality Hospitals.

<i>The Truth Pill</i> 2022 book by Dinesh Thakur and Prashant Reddy

The Truth Pill: The Myth of Drug Regulation in India is a 2022 book by whistleblower Dinesh Thakur and lawyer Prashant Reddy. The book highlights the problems in India's drug regulatory framework, and the government oversight relating to poor manufacturing practices and clinical trials of drugs by Indian pharmaceutical companies.

References

  1. 1 2 "Wockhardt posts net loss of Rs 237 crore in Q4 FY 23". The Economic Times. 27 May 2023. Retrieved 2 March 2024.
  2. ↑ "Wockhardt acquires US-based Morton Grove". The Economic Times. 24 October 2007. Retrieved 16 February 2023.
  3. ↑ "Audited Financial Results For The Quarter And Year Ended 31.03.2021" (PDF). BSE. Retrieved 27 May 2021.
  4. ↑ "Wockhardt – Who we are".
  5. 1 2 3 Sanju Verma, Amit Shah (2007). "Wockhardt: "Wock"ing the talk..." (PDF). HDFC Securities. India Research.
  6. ↑ "Wockhardt set to join billion-dollar club". Business Standard India. Business Standard. 20 March 2013. Retrieved 20 March 2013.
  7. ↑ "Wockhardt Chairman's Profile". wockhardt.com. Retrieved 13 February 2017.
  8. ↑ Priyanka Sangani (28 March 2008). "Marginal business logic". The Economic Times.
  9. ↑ "Wockhardt Limited". Archived from the original on 20 October 2007. Retrieved 9 May 2009.
  10. ↑ T. Surendar, Charles Assisi (18 January 2008). "We need a Nano for medicines too". The Times of India.
  11. ↑ Dec 22, PTILast Updated (22 December 2022). "Indian pharma sector set for 'volume to value leadership' journey in 2023". The Economic Times. ISSN   0013-0389 . Retrieved 6 August 2023.{{cite news}}: CS1 maint: numeric names: authors list (link)
  12. ↑ "Introducing IPA- Indian Pharmaceutical Alliance". IPA, Indian Pharmaceutical Alliance. Retrieved 6 August 2023.
  13. ↑ "Introducing Wockhardt" . Retrieved 9 May 2009.
  14. ↑ "Wockhardt sells nutrition biz to Danone for Rs 1,576 cr". Business Standard India. 3 August 2011. Retrieved 25 January 2023.
  15. ↑ "UK extends COVID-19 vaccine supply deal with India's Wockhardt by 6 months". Mint. 10 February 2021.
  16. ↑ "Wockhardt: the company helping to vaccinate Britain". Financial Times. Retrieved 28 June 2021.
  17. ↑ "Wockhardt to produce, supply Sputnik V, Sputnik Light Covid vaccine". mint. 13 August 2021. Retrieved 21 September 2021.
  18. ↑ "UPDATE 1-Wockhardt buys US Morton Grove for $38 mln". Reuters. 24 October 2007 – via www.reuters.com.
  19. ↑ Shobhana Subramanian (3 April 2009). "Newsmaker: Habil F Khorakiwala, Scientist in a hurry". Business Standard India. Business Standard.
  20. ↑ "Wockhardt | Who we are | Board of Directors". www.wockhardt.com. Retrieved 5 November 2022.
  21. ↑ Bella, Timothy (9 March 2017). "Hip-Hop's Unlikeliest Icons: Promethazine Codeine Syrup Manufacturers". Bloomberg. Retrieved 17 May 2022.
  22. ↑ Rafael Arroyo (12 February 2013). "CGMP/Finished Pharmaceuticals/Adulterated,(WL: 320-14-01)". FDA.
  23. ↑ Maan Abduldayem (18 July 2013). "CGMP/Finished Pharmaceuticals/Adulterated,(WL: 320-13-21)". FDA.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.